Life ScienceCompany
Melinta Therapeutics - Fusidic Acid Ownership
Who owns Melinta Therapeutics - Fusidic Acid?
Melinta Therapeutics - Fusidic Acid is owned by Arrevus. It was acquired on February 5, 2019.
Melinta Therapeutics - Fusidic Acid Business Overview
Where is Melinta Therapeutics - Fusidic Acid headquartered?
Melinta Therapeutics - Fusidic Acid is headquartered in New Haven, Connecticut.
What sector is Melinta Therapeutics - Fusidic Acid in?
Melinta Therapeutics - Fusidic Acid is a life science company.
Life Science M&A Summary in 2019
Out of 60 sectors in the Mergr database, life science ranked 9 in number of deals in 2019. The largest life science acquisition in 2019 was Celgene - which was acquired by Bristol-Myers Squibb for $74.0B.
Join Mergr to view all 252 acquisitions of life science companies in 2019, including 45 acquisitions by private equity firms, and 207 by strategics.